163 related articles for article (PubMed ID: 3414699)
1. Pharmacist management of antiemetic therapy under protocol in an oncology clinic.
Martin JK; Norwood MB
Am J Hosp Pharm; 1988 Jun; 45(6):1322-8. PubMed ID: 3414699
[TBL] [Abstract][Full Text] [Related]
2. Evolving roles of oncology pharmacists in Singapore: a survey on prescribing patterns of antiemetics for chemotherapy induced nausea and vomiting (CINV) at a cancer centre.
Chan A; Shih V; Chew L
J Oncol Pharm Pract; 2008 Mar; 14(1):23-9. PubMed ID: 18337437
[TBL] [Abstract][Full Text] [Related]
3. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
Herrstedt J
Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and cost effectiveness of new antiemetic guidelines.
Engstrom C; Hernandez I; Haywood J; Lilenbaum R
Oncol Nurs Forum; 1999 Oct; 26(9):1453-8. PubMed ID: 11064877
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the management of nausea and vomiting caused by antineoplastic agents.
Merrifield KR; Chaffee BJ
Clin Pharm; 1989 Mar; 8(3):187-99. PubMed ID: 2650957
[TBL] [Abstract][Full Text] [Related]
6. Relieving nausea and vomiting in patients with cancer: a treatment algorithm.
Johnson MH; Moroney CE; Gay CF
Oncol Nurs Forum; 1997; 24(1):51-7. PubMed ID: 9007907
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and antiemetic management of chemotherapy-induced nausea and vomiting.
Goodman M
Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):20-32. PubMed ID: 9282378
[TBL] [Abstract][Full Text] [Related]
8. Pharmacist involvement in a thyroid clinic.
Dong BJ
Am J Hosp Pharm; 1990 Feb; 47(2):356-61. PubMed ID: 2309725
[TBL] [Abstract][Full Text] [Related]
9. Nurses' perceptions of antiemetic effectiveness.
Rhodes VA; McDaniel RW; Simms SG; Johnson M
Oncol Nurs Forum; 1995 Sep; 22(8):1243-52. PubMed ID: 8532549
[TBL] [Abstract][Full Text] [Related]
10. Providing clinical pharmacy services in an AIDS--oncology ambulatory-care clinic.
Wong RJ; Volberding PA
Am J Hosp Pharm; 1988 Nov; 45(11):2351-4. PubMed ID: 2852473
[TBL] [Abstract][Full Text] [Related]
11. Closing the gap in prophylactic antiemetic therapy: patient factors in calculating the emetogenic potential of chemotherapy.
Doherty KM
Clin J Oncol Nurs; 1999 Jul; 3(3):113-9. PubMed ID: 10690042
[TBL] [Abstract][Full Text] [Related]
12. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
Poli-Bigelli S; Rodrigues-Pereira J; Carides AD; Julie Ma G; Eldridge K; Hipple A; Evans JK; Horgan KJ; Lawson F;
Cancer; 2003 Jun; 97(12):3090-8. PubMed ID: 12784346
[TBL] [Abstract][Full Text] [Related]
13. [Role of the hospital pharmacist in the management of chemotherapy-induced nausea and vomiting].
Breton D; Jandard V; Cauet A; Paillet M; Galvez O; Faure A; Camus G; Beltrando X; Rimlinger H; Hervouet M; Margery J; Bohand X; Vaylet F
J Pharm Belg; 2011 Jun; (2):46-50. PubMed ID: 21823442
[No Abstract] [Full Text] [Related]
14. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
15. [The control of chemotherapy-induced nausea and vomiting].
Shinkai T; Saijo N; Sawamura N; Funaki U; Takahashi S; Yokoyama S; Fujita J; Futami H; Sasaki Y; Shimizu E
Gan No Rinsho; 1985 Jun; 31(7):779-91. PubMed ID: 3897622
[TBL] [Abstract][Full Text] [Related]
16. Optimising antiemetic therapy: what are the problems and how can they be overcome?
Aapro M
Curr Med Res Opin; 2005 Jun; 21(6):885-97. PubMed ID: 15969889
[TBL] [Abstract][Full Text] [Related]
17. Cost-reducing treatment algorithms for antineoplastic drug-induced nausea and vomiting.
Berard CM; Mahoney CD
Am J Health Syst Pharm; 1995 Sep; 52(17):1879-85. PubMed ID: 8528849
[TBL] [Abstract][Full Text] [Related]
18. Management of vomiting associated with cytotoxic therapy.
Jones AL; Cunningham D
Br J Hosp Med; 1991 Feb; 45(2):85-8. PubMed ID: 2018889
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy-induced nausea and vomiting. Easing patients' fear and discomfort with effective antiemetic regimens.
Bilgrami S; Fallon BG
Postgrad Med; 1993 Oct; 94(5):55-8, 62-4. PubMed ID: 8415336
[TBL] [Abstract][Full Text] [Related]
20. Comparative activity of antiemetic drugs.
Jordan K; Schmoll HJ; Aapro MS
Crit Rev Oncol Hematol; 2007 Feb; 61(2):162-75. PubMed ID: 17208005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
